Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$259K Sell
66,148
-9,497
-13% -$27.5K ﹤0.01% 5764
2025
Q4
$143K Sell
75,645
-7,107
-9% -$13.1K ﹤0.01% 6055
2025
Q3
$165K Buy
82,752
+5,514
+7% +$11.3K ﹤0.01% 5962
2025
Q2
$151K Sell
77,238
-21,836
-22% -$37.6K ﹤0.01% 5962
2025
Q1
$151K Sell
99,074
-2,132
-2% -$3.99K ﹤0.01% 5846
2024
Q4
$201K Buy
101,206
+5,135
+5% +$12.2K ﹤0.01% 5783
2024
Q3
$213K Buy
96,071
+2,177
+2% +$5.73K ﹤0.01% 5735
2024
Q2
$287K Buy
93,894
+8,217
+10% +$22K ﹤0.01% 5518
2024
Q1
$240K Sell
85,677
-207,765
-71% -$647K ﹤0.01% 5666
2023
Q4
$567K Buy
293,442
+188,225
+179% +$284K ﹤0.01% 5568
2023
Q3
$161K Buy
105,217
+49,949
+90% +$68.4K ﹤0.01% 5682
2023
Q2
$81.8K Buy
55,268
+46,078
+501% +$63.2K ﹤0.01% 6031
2023
Q1
$13.3K Buy
9,190
+1,245
+16% +$2.12K ﹤0.01% 6777
2022
Q4
$10.5K Sell
7,945
-1,255,891
-99% -$1.43M ﹤0.01% 6917
2022
Q3
$1.62M Sell
1,263,836
-1,131,744
-47% -$1.79M ﹤0.01% 4577
2022
Q2
$4.95M Buy
2,395,580
+1,009,107
+73% +$3.05M ﹤0.01% 3780
2022
Q1
$4.85M Buy
1,386,473
+794
+0.1% +$4.99K ﹤0.01% 3717
2021
Q4
$11.2M Buy
1,385,679
+1,201
+0.1% +$12.3K ﹤0.01% 2831
2021
Q3
$19.9M Sell
1,384,478
-29,797
-2% -$489K ﹤0.01% 2090
2021
Q2
$19.2M Buy
1,414,275
+959,259
+211% +$13.4M ﹤0.01% 2196
2021
Q1
$8.17M Buy
+455,016
New +$10.4M ﹤0.01% 2858

Other funds holding ADAG

Morgan Stanley's ADAG Position: Q1 2026 in Review

Morgan Stanley reduced its Adagene (ADAG) stake by 13% in Q1 2026, selling an estimated $27.5K and leaving 66,148 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #5764.

Morgan Stanley first reported a position in ADAG in Q1 2021 and has held it in 21 quarters since. The position peaked at $19.9M in Q3 2021. 25 funds tracked by Wall St. Rank hold ADAG as of Q1 2026.

  • Morgan Stanley held 66,148 shares of Adagene worth $259K as of Q1 2026.
  • Morgan Stanley sold 9,497 Adagene shares in Q1 2026, an estimated $27.5K.
  • Adagene made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5764 holding.
  • Morgan Stanley first reported a position in Adagene in Q1 2021 and has held it in 21 quarters since.
  • Morgan Stanley's Adagene position peaked at $19.9M in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Adagene as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.